Old Web
English
Sign In
Acemap
>
authorDetail
>
Weizhong Zhang
Weizhong Zhang
Shanghai Jiao Tong University
Blood pressure
Medicine
Internal medicine
Aliskiren
Randomized controlled trial
5
Papers
146
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of Chronic Comorbidities on Progression and Prognosis in Patients with COVID-19: A Retrospective Cohort Study in 1031 Hospitalized Cases in Wuhan, China
2020
Social Science Research Network
Hesong Zeng
Tianlu Zhang
Xingwei He
Yuxin Du
Yan Tong
Xueli Wang
Weizhong Zhang
Yin Shen
Show All
Source
Cite
Save
Citations (0)
Impact of Chronic Comorbidities on Progression and Prognosis in Patients with COVID-19: A Retrospective Cohort Study in 1031 Hospitalized Cases in Wuhan, China
2020
medRxiv
Hesong Zeng
Tianlu Zhang
Xingwei He
Yuxin Du
Yan Tong
Weizhong Zhang
Yin Shen
Show All
Source
Cite
Save
Citations (7)
[Preliminary clinical study of direct renin inhibitor aliskiren in the treatment of severe COVID-19 patients with hypertension].
2020
Chinese Journal of Internal Medicine
Yan Guo
Jia Zeng
Qiang Li
Pan Li
Fengming Luo
Weizhong Zhang
Yongxin Lu
Qing Wang
Wei Zhang
Zhengpei Zeng
Li-sheng Liu
Show All
Source
Cite
Save
Citations (2)
Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association
2011
Hypertension Research
Ji-Guang Wang
Kazuomi Kario
Titus Lau
Yong Quek Wei
Chang Gyu Park
Cheol-Ho Kim
Jun Huang
Weizhong Zhang
Yong Li
Peter Yan
Dayi Hu
Show All
Source
Cite
Save
Citations (55)
1